Dermatology (Basel, Switzerland)
Clinical phenotype transition in pemphigus may suggest undertreatment with rituximab: findings from a retrospective single-centre analysis of relapsed patients.
Anne-Lise Strandmoe, Marjolein A J Hiel, Joost M Meijer, Laura L van Nijen-Vos, A Miranda Nijenhuis, L Joost van Pelt, Gonnie H J Meijer, Peter Heeringa, Gilles F H Diercks, Jeroen Bremer, Barbara Horváth
Published: 202610.1159/000550300
Abstract
Introduction Pemphigus is an autoimmune bullous disease caused by autoantibodies against desmoglein (DSG) 1 and/or 3 and comprises two main subtypes: pemphigus vulgaris (PV) and pemphigus foliaceus (PF). PV affects the skin and/or mucosa and includes…
Preview only. Read the full abstract at the source